Maa: Uusi-Seelanti
Kieli: englanti
Lähde: Medsafe (Medicines Safety Authority)
Triamcinolone acetonide 0.05%; ;
Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Triamcinolone acetonide 0.05%
0.05 %
Topical ointment
Active: Triamcinolone acetonide 0.05% Excipient: White soft paraffin
Tube, 30g, 30 g
Prescription
Prescription
Pharmacia & Upjohn Company LLC
Package - Contents - Shelf Life: Tube, - 30 g - 24 months from date of manufacture stored at or below 25°C - Tube, - 100 g - 24 months from date of manufacture stored at or below 25°C
1969-12-31
Aristocort NZ CMI.doc 1 NEW ZEALAND CONSUMER MEDICINE INFORMATION ARISTOCORT® _ _ _Triamcinolone acetonide cream and ointment _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ARISTOCORT. It does not contain all the available information. It does not use the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using ARISTOCORT against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT ARISTOCORT IS USED FOR ARISTOCORT is a type of cortisone and belongs to the group of medicines called corticosteroids. It is available as both a cream and an ointment._ _ ARISTOCORT is used on the skin to relieve the redness, swelling, itching and discomfort of many skin problems such as: • psoriasis (a stubborn skin disorder with raised, rough, reddened areas covered with dry, fine silvery scales) • eczema (an often itchy skin condition with redness, swelling, oozing of fluid, crusting which may lead to scaling) • other types of skin disease (dermatitis) • itching on the anus or vulva • inflammation of the external part of the ear Your doctor may have prescribed ARISTOCORT for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. ARISTOCORT is not addictive. This medicine is available only with a doctor’s prescription. BEFORE YOU USE ARISTOCORT _WHEN YOU MUST NOT USE IT _ DO NOT USE ARISTOCORT IF: 1. YOU HAVE AN ALLERGY TO: • triamcinolone acetonide • any of the ingredients in ARISTOCORT listed at the end of this leaflet 2. YOU HAVE A VIRAL SKIN INFECTION (SUCH AS COLD SORES, S Lue koko asiakirja
ARISTOCORT topical cream and topical ointment – Data Sheet Page 1 of 9 NEW ZEALAND DATA SHEET 1. PRODUCT NAME ARISTOCORT topical cream & ARISTOCORT topical ointment 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: 0.02% w/w triamcinolone acetonide. Triamcinolone acetonide is a white or almost white crystalline powder. Triamcinolone acetonide 11 mg is approximately equivalent to 10 mg of triamcinolone. It is practically insoluble in water, sparingly soluble in alcohol, very slightly soluble in ether. The molecular formula of triamcinolone acetonide is C 24 H 31 FO 6 with a molecular weight of 434.5. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM ARISTOCORT cream is a smooth, white opaque homogeneous cream, free of visible contamination. ARISTOCORT ointment is an off white, smooth, homogeneous opaque ointment, free of visible contamination. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS In the treatment of the following dermatoses; atopic dermatitis, eczematous dermatitis, nummular eczema, contact dermatitis, anal and vulval pruritus, otitis externa, seborrhoeic dermatitis, eczematised psoriasis, neurodermatitis. 4.2 DOSE AND METHOD OF ADMINISTRATION Apply in small quantities to the affected areas three or four times daily. Some cases of eczematised psoriasis may be treated more effectively by the application of ARISTOCORT under an occlusive nonpermeable dressing. 4.3 CONTRAINDICATIONS Tuberculosis of the skin, fungal infections and viral diseases of the skin Herpes simplex, chicken-pox and baccinia). Hypersensitivity to any component of the cream or ointment. ARISTOCORT topical cream and topical ointment – Data Sheet Page 2 of 9 Not to be used in the eye. Topical steroids should not be used in patients with markedly impaired circulation since skin ulceration has occurred in these patients following the use of corticosteroids. Topical steroids should be used with caution and occlusive dressings should not be used in patients with primary skin infe Lue koko asiakirja